Clincosm LogoSign in Get a demo

colorectal cancer

Showing NaN - NaN of 143
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Solid Tumor, Breast Cancer, Pancreatic Cancer Trial in United States (SON-DP)

Recruiting
  • Solid Tumor
  • +4 more
  • Gilbert, Arizona
  • +4 more
Aug 4, 2023

Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 31, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)

Not yet recruiting
  • Colon Cancer
  • Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Advanced Solid Tumors, Lymphoma, Gastric Cancer Trial in United States (FT500, Nivolumab, Pembrolizumab)

Completed
  • Advanced Solid Tumors
  • +17 more
  • San Diego, California
  • +3 more
Jan 27, 2023

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Cutaneous Melanoma, Pleural Mesothelioma, HER2 Negative Breast Tumors Trial in Worldwide (SGN-CD228A)

Active, not recruiting
  • Cutaneous Melanoma
  • +5 more
  • Birmingham, Alabama
  • +13 more
Jan 23, 2023

Breast Cancer, Colorectal Cancer Trial in Houston (Genetic Testing and Counseling, Screening Form)

Recruiting
  • Breast Cancer
  • Colorectal Cancer
  • Genetic Testing and Counseling
  • Screening Form
  • Houston, Texas
    MD Anderson Cancer Center
Jan 20, 2023

a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

Recruiting
  • Colorectal Cancer
    • Phoenix, Arizona
    • +46 more
    Jan 18, 2023

    Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

    Recruiting
    • Minimal Residual Disease
    • +11 more
    • ELI-002 2P
    • Duarte, California
    • +10 more
    Jan 18, 2023

    An Optimized Multi-Target Stool DNA Test, for Colorectal Cancer

    Active, not recruiting
    • Colorectal Cancer
    • mt-sDNA 2.0 screening test
    • +2 more
    • Birmingham, Alabama
    • +191 more
    Jan 9, 2023

    2019-01: "Clinical Validation ofOptimized Multi-Target Stool DNA

    Active, not recruiting
    • Colorectal Cancer
    • Blood Sample Collection
    • Birmingham, Alabama
    • +189 more
    Jan 9, 2023

    Solid Tumor, Colorectal Cancer, Gastric Cancer Trial in United States (IGM-8444, FOLFIRI, Bevacizumab (and approved

    Recruiting
    • Solid Tumor
    • +7 more
    • Duarte, California
    • +11 more
    Jan 6, 2023

    NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)

    Completed
    • Non-small Cell Lung Cancer
    • +9 more
    • Little Rock, Arkansas
    • +32 more
    Dec 12, 2022

    Ovarian Cancer, Breast Cancer, Colorectal Cancer Trial in Houston (Genetic Testing and Counseling, Screening Form)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Genetic Testing and Counseling
    • Screening Form
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 12, 2022

    Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029

    Terminated
    Has Results
    • Colorectal Cancer
    • +6 more
    • GEN1029 (HexaBody®-DR5/DR5)
    • New Haven, Connecticut
    • +5 more
    Nov 11, 2022

    T Cells, Colorectal Cancer, Lynch Syndrome Trial in Houston (Naproxen, Aspirin)

    Not yet recruiting
    • T Cells
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Nov 23, 2022

    Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

    Recruiting
    • Advanced Solid Tumor
    • +7 more
    • PY159 Single agent dose level 1
    • +17 more
    • San Francisco, California
    • +11 more
    Nov 3, 2022

    Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T

    Recruiting
    • Breast Cancer
    • +8 more
    • San Francisco, California
    • +4 more
    Oct 26, 2022

    Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

    Completed
    • Melanoma
    • +25 more
    • Scottsdale, Arizona
    • +10 more
    Sep 27, 2022

    Biomarkers in Subjects With Untreated Solid Tumors

    Completed
    • Breast Cancer
    • +12 more
    • Blood Sample Collection
    • Phoenix, Arizona
    • +118 more
    Aug 31, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Colorectal Cancer Trial in Worldwide (Obinutuzumab, Atezolizumab, Cibisatamab)

    Active, not recruiting
    • Colorectal Cancer
    • Los Angeles, California
    • +12 more
    Aug 19, 2022